Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development

Cell Growth and Differentiation

Volumn 7, Issue 11, 1996, Pages 1551-1561

  Huynh, Duong P ^b   Tran, Tien M D ^b   Nechiporuk, Tamilla ^b   Pulst, Stefan M ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GENE PRODUCT; MESSENGER RNA; PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; EMBRYO; FETUS; FETUS DEVELOPMENT; GENE; GENE EXPRESSION; GENE SEQUENCE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LENS; MICROSCOPY; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, NEUROFIBROMATOSIS 2; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM; NEUROFIBROMATOSIS 2; NEUROFIBROMIN 2; ORGAN SPECIFICITY; RNA, MESSENGER; RNA, NEOPLASM;

ANIMALIA; FALCO COLUMBARIUS;

EID: 0029958637     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Martuza, R. L., and Eldridge, R. Neurofibromatosis 2: bilateral acoustic neurofibromatosis. N. Engl. J. Med., 318: 684-688, 1988.
2. Evans, D. G. R., Huson, S. M., Donnai, D., Neary, W., Blair, V., Teare, D., Newton, V., Strachan, T., Ramsden, R., and Harris, R. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J. Med. Genet., 29: 841-846, 1992.
3. Evans, D. G. R., Huson, S. M., Donnai, D. Neary, W., Blair, V., Newton, V., Strachan, T., and Harris, R. Agenetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counseling. J. Med. Genet., 29: 847-852, 1992.
4. Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S., Lenoir, G., Bijisma, E., Fashold, R., Dumanski, J., de Jong, P., Parry, D., Eldridge, R., Aurias, A., Delattre, O., and Thomas, G. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (Lond.), 363: 515-521, 1993.
5. Trofatter, J. A., MacCollin, M. M., Rutter, J. L., Murrell, J. R., Duyao, M. P., Parry, D. M., Eldridge, R., Kley, N., Menon, A. G., Pulaski, K., Haase, V. H., Ambrose, C. M., Munroe, D., Bove, C., Haines, J. L., Martuza, R. L., MacDonald, M. E., Seizinger, B. R., Short, M. P., Buckler, A. J., and Gusella, J. F. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 792-800, 1993.
6. Lankes, W. T., and Furthmayr, H. Moesin: a member of the protein 4.1-talin ezrin family of proteins. Proc. Natl. Acad. Sci. USA, 88: 8297-8301, 1991.
7. Gould, K. L., Bretscher, A., Esch, F. S., and Hunter, T. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J., 8: 4133-4142, 1989.
8. Funayama, N., Ngafuchi, A., Sato, N., Tsukita, S., and Tsukita, S. Radixin is a novel member of the band 4.1 family. J. Cell Biol., 115: 1039-1048, 1991.
9. Sainz, J., Huynh, D. P., Figueroa, K., Ragge, N. K., Baser, M. E., and Pulst, S-M. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet., 3: 885-891, 1994.
10. Jacoby, J. B., MacCollin, M., Louis, D. N., Mohney, T., Rubio, M. P., Pulaski, K., Trofatter, J. A., Kley, N., Seinzinger, B., Vijaya, R., and Gusella, J. F. Exon scanning for mutation of the NF2 gene in schwannomas. Hum. Mol. Genet., 3: 413-419, 1994.
11. Ruttledge, M. H., Sarrazin, J., Rangaratnam, S., Phelan, C. M., Twist, E., Merel, P., Delattre, O., Thomas, G., Nordenskjold, M., Collins, P. V., Dumanski, J. P., and Rouleau, G. A. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat. Genet., 6: 180-184, 1994.
12. Huynh, D. P., and Pulst, S.W. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and alteration of cell morphology in STS26T and T98G cells. Oncogene, 13: 73-84, 1996.
13. Claudio, J. O., Marineau, C., and Rouleau, G. A. The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Hum. Mol. Genet., 3: 185-190, 1994.
14. Haase, V. H., Trofatter, J. A., MacCollin, M., Tarttelin, E., Gusella, J. F., and Ramesh, V. The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms. Hum. Mol. Genet., 3: 407-411, 1994.
15. Huynh, D. P., Nechiporuk, T., and Pulst, S. M. Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Hum. Mol. Genet., 3: 1075-1079, 1994.
16. Bianchi, A. B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A. J. P., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F., Seizinger, B. R., and Kley, N. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types. Nat. Genet., 6: 185-192, 1994.
17. Pykett, M. J., Murphy, M., Harnish, P. R., and George, D. L. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum. Mol. Genet., 8: 559-564, 1994.
18. Hara, T., Bianchi, A. B., Seizinger, B. R., and Kley, N. Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res. 54: 330-335, 1994.
19. Takeshima, H., Ichiro, I., Lee, P. S. Y., Safdar, N., Levin, V. A., and Saya, H. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene, 9: 2135-2144, 1994.
20. Claudio, J. O., Lutchman M., and Rouleau, G. A. Widespread but cell type specific expression of the mouse neurofibromatosis type 2 gene. Neuroreport, 6: 1942-1946, 1995.
21. Bernards, R., Schackleford, G. M., Gerber, M. R., Horowitz, J. M., Friend, S. H., Schartl, M., Bogenmann, E., Raaport, J. M., McGee, T., Dryja, T. P., and Weinberg, R. A. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. USA, 86: 6474-6478, 1989.
22. Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., and te Riele, H. Requirement for a functional Rb-1 gene in murine development. Nature (Lond.), 359: 328-330, 1992.
23. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
24. Huang, A., Campell, C. E., Bonetta, L., McAndrews-Hill, M. S., Chilton-MacNeill, S., Coppes, M. J., Law, D. J., Feinberg, A. P., Yeger, H., and Williams, B. R. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science (Washington DC), 250: 991-993, 1990.
25. Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., and Weinberg, R. A. Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat. Genet., 7: 353-361, 1994.
26. Lee, E. Y. H. P., Chang, C. Y., Hu, N., Wang, Y. C. J., Lai, C. C., Herrup, K., Lee, W. H., and Bradley, A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (Lond.), 359: 288-294, 1992.
27. Rogel, A., Popliker, M., Webb, C. G., and Oren, M. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol., 5: 2851-2855, 1985.
28. Huynh, D. P., Nechiporuk, T., and Pulst, S. M. Expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev. Biol., 161: 538-551, 1994.
29. Daston, M. M., and Ratner, N. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn., 195: 216-226, 1992.
30. Rauscher, F. J., III The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J., 7: 896-903, 1993.
31. Wiman, K. G. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J., 7: 841-845, 1993.
32. Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., and Copeland, N. G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev., 8: 1019-1029, 1994.
33. Kreidberg, J. A., Hannu, S., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 required for early kidney development. Cell, 74: 679-691, 1993.
34. Kaufman, M. H. The Atlas of Mouse Development. San Diego, CA: Academic Press, 1992.
35. Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., Koski, R. A., Lu, H. S., and Yarden, R. A. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69: 559-572, 1992.
36. Wen, D., Suggs, S. V., Karunagaran, D., Liu, N., Cupples, R. L., Luo, Y., Janssen, A. M., Ben-Baruch, N., Trollinger, D. B., Jacobsen, V. L., Meng, S. Y., Lu, H. S., Hu, S., Chang, D., Yang, W., Yanigahara, D., Koski, R. A., and Yarden, Y. Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell. Biol., 14: 1909-1919, 1994.
37. Shah, N. M., Marchionni, M. A., Isaacs, I., Stroobant, P., and Anderson, D. J. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell, 77: 349-360, 1994.
38. Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky R., and Jessen, K. R. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation and maturation of rat Schwann cell precursors. Neuron, 15: 585-596, 1995.
39. den Bakker, M. A., Riegman, P. H. J., Hekman, R. A. C. P., Boersma, W., Janssen, P. J. A., Kwast, T. H., and Zwarthoff, E. The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene, 10: 757-763, 1995.
40. Arakawa, H., Hayashi, N., Nagase, H., Ogawa, M., and Nakamura, Y. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum. Mol. Genet., 3: 565-568, 1994.
41. Gutmann, D. H., Wright, D. E., Geist, R. T., and Snider, W. D. Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development. Hum. Mol. Genet., 4: 471-478, 1995.
42. Birgbauer, E., Dinsmore, J. H., Winckler, B., Lander, A. D., and Solomon, F. Association of ezrin isoforms with the neuronal cytoskeleton. J. Neurosci. Res., 30: 232-341, 1991.
43. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., and Zoller, M. Participation in normal immune responses of a metastasis inducing splice variant of CD44. Science (Washington DC), 257: 682-685, 1992.
44. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
45. Koopman, G., Heider, K. H., Horst, E., Adolf, G. R., van den Berg., F., Ponta, H., Herrlich, P., and Pals, S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rate metastasis associated variant of CD44. J. Exp. Med., 177: 897-904, 1993.
46. MacCollin, M., Ramesh, V., Jacoby, L. B., Louis, D. N., Rubio, M. P., Pulaski, K., Trofatter, J. A., Short, M. P., Bove, C., Eldridge, R., Parry, D. M., and Gusella, J. F. Mutational analysis of patients with neurofibromatosis 2. Am. J. Hum. Genet., 55: 314-320, 1994.
47. Merel, P., Hoang-Xuan, K., Sanson, M., Bujlsma, E., Rouleau, G., Laurent-Puig, P., Pulst, S. M., Baser, M., Lenoir, G., Sterkers, J. M., Philippon, J., Resche, F., Mautner, V., Fischer, G., Hulsebos.T., Aurjas, A., Delattre, O., and Thomas, G. Screening for germ-line mutations in the NF2 gene. Genes Chromosomes & Cancer., 12: 117-127, 1995.
48. Rubio, M. P., Correa, K. M., Ramesh, V., MacCollin, M. M., Jacoby, L. B., von Deimling, A., Gusella, J. F., and Louis, D. N. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res., 54: 45-47, 1994.
49. Mautner, V., Lindenau, M., Hazim, W., Tatagiba, M., Haase, W., Samii, M., Wais, R., and Pulst, S. M. The neuroimaging and ocular spectrum of neurofibromatosis type 2. Neurosurgery, 38: 880-886, 1996.
50. Ragge, K. N., Baser, M., Klein, J., Nechiporuk, A., Sainz, J., Pulst, S. M., and Riccardi, V. M. Ocular abnormalities in neurofibromatosis type 2. Am. J. Ophthalmol., 120: 634-641, 1995.
51. Towbin, H., Staehelin, T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
52. Young, S. W., III In situ hybridization with oligodeoxynucleotide probes. In: D. G. Wilkinson (ed.), In Situ Hybridization: A Practical Approach, pp. 33-44. New York: Oxford University Press, 1992.